{"date":"2025-03-01","count":1,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7607-2025-03-01-1004-1jkfq5t","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-03-01","time":"10:04:21","subject":"公告本公司與日本株式會社A&i簽訂技術授權協議","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-03-01 10:04，「公告本公司與日本株式會社A&i簽訂技術授權協議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}